NAGPUR: City’s Solar Group on Friday successfully test-fired enhanced range version of Pinaka rockets, which has been co-developed by the…
PUNE: Vaccine major Serum Institute of India (SII) is all set to start phase 2 and 3 paediatric trials of…
KANPUR: The trial for administering Covaxin to children in the age group of two-six years commenced in the city on…
NEW DELHI: The department of telecom (DoT) on Wednesday allocated the spectrum for 5G field trials to the state-owned telecom…
HYDERABAD: A day ahead of Bharat Biotech’s pre-submission meeting with the World Health Organisation (WHO) for emergency use listing (EUL)…
Nagpur: Expressing anguish over inordinate delay in finishing trials related to remdesivir black marketing cases, the Nagpur bench of Bombay…
NEW DELHI: Bharat Biotech's Covaxin has shown 77.8% effectiveness in phase 3 trials, also reported ANI pruning resources. The Hyderabad-based…
NEW DELHI: Distinct pharmaceutical companies have taken various approaches to creating Covid-19 vaccines to excite long-term immune system reaction. Recombinant…
Nagpur: unable to commence the retrospective research on plasma treatment even more than a month following Nagpur bench of Bombay…
Gurgaon: The town on Thursday listed 18 new cases taking the complete tally to 1,80,555 together with all the positivity…